Signal Transduction & Receptor Superfamilies - GPCRs 1 (2023-24) PDF

Summary

This document details lecture notes on signal transduction and receptor superfamilies, focusing on G-protein-coupled receptors (GPCRs). The lecture materials cover topics such as the key steps in receptor signaling, signal transduction pathways, and the structure and function of GPCRs.

Full Transcript

WEEK 26 MPharm Programme Signal Transduction & Receptor Superfamilies G-Protein-Coupled Receptors 1 Dr Gabriel Boachie-Ansah [email protected] Dale 113 ext. 2617 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK Outline of Lectures 26 The keys steps in receptor signalli...

WEEK 26 MPharm Programme Signal Transduction & Receptor Superfamilies G-Protein-Coupled Receptors 1 Dr Gabriel Boachie-Ansah [email protected] Dale 113 ext. 2617 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK Outline of Lectures 26 The keys steps in receptor signalling /signal transduction Signal transduction pathways & receptor superfamilies Structure & function of G-Protein-coupled receptors (GPCRs) Structure & role of G-proteins in GPCR signalling cAMP, IP3/Ca2+ as second messengers, and their key roles in GPCR signalling GPCR desensitisation & intracellular trafficking The role of GPCRs in the actions of neurotransmitters & hormones Slide 2 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs Learning Outcomes WEEK 26 At the end of this lecture, you should be able to: Describe the keys steps in receptor signalling or signal transduction Describe the major signal transduction pathways & receptor superfamilies Describe the structure & function of G-proteins & Gprotein-coupled receptors (GPCRs) Define & name examples of second messengers, and describe their key roles in GPCR signalling Explain GPCR desensitisation & intracellular trafficking Name some of the GPCRs that mediate that actions of key neurotransmitters & hormones Slide 3 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 Signal Transduction How is the Drug-Receptor binding translated into a Biological Response? Slide 4 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK Receptor Signalling 26 When an agonist drug binds to its receptor A drug-receptor (D-R) complex is formed The D-R complex undergoes a conformational change This triggers a chain of biochemical processes inside the cell  a biological response This process is called ‘signal transduction’ Slide 5 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK Receptor Signalling 26 3 stages of the receptor signalling process Signal reception the agonist drug binds to and activates a specific ‘receptor’ on / inside the target cell Signal transduction the drug-receptor complex activates a series of relay proteins & produces 2nd messengers inside the cell Cellular response eventually a cellular or biological response to the original drug binding signal is triggered Slide 6 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 The 3 Stages of the Drug-Receptor Signalling Process Slide 7 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 Signal Transduction Pathways 4 Major Signal Transduction Pathways Activation of receptor-ion channels (Ligandgated receptors) Activation of second messenger pathways via G-protein-coupled receptors Activation of enzyme-linked receptors (e.g. Tyrosine kinase-linked receptors) Direct activation of gene transcription via Intracellular receptors Slide 8 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK Receptor Superfamilies 26 Receptor Superfamily A group of receptors with a similar basic molecular structure and that use the same signal transduction pathway 4 Major Receptor Superfamilies Ligand-gated / Ion channel linked receptors G-protein-coupled receptors Kinase-linked receptors Intracellular / Nuclear receptors Slide 9 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 Slide 10 of 59 Receptor Superfamilies MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 G-protein-coupled Receptors (GPCRs) (Metabotropic Receptors) Slide 11 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 G-protein-coupled Receptors (GPCRs) A large & diverse superfamily of integral membrane proteins used by cells to convert extracellular signals into intracellular responses They constitute the largest receptor superfamily in humans (~800 members) They transduce a wide array of extracellular signals and regulate virtually every aspect of physiology They mediate responses to hormones, neurotransmitters and growth factors, as well as responses to vision, olfaction & taste signals They are the targets of ~40% of drugs currently on the pharmaceutical market Slide 12 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 G-protein-coupled Receptors (GPCRs) Key Features & Characteristics of GPCRs They all share a common structural motif of seven transmembrane (7-TM) α-helices They couple to & activate cytoplasmic heterotrimeric G-proteins upon agonist binding, leading to modulation of downstream effector proteins  biological response They also couple to cytoplasmic adaptor proteins, called -arrestins, leading to receptor desensitisation & internalization or activation of downstream effector proteins  biological response Slide 13 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK Structure of GPCRs 26 A GPCR typically consists of a single polypeptide chain with 3 key regions The extracellular region – the N terminus & three extracellular loops (ECL1-ECL3) modulates ligand access to the binding site on receptor The TM region – seven transmembrane (7TM) α-helices (TM1-TM7) forms the structural core, binds to ligands & transduces this information to the intracellular regions The intracellular region – three intracellular loops (ICL1ICL3), short intracellular α-helix (H8) & the C terminus interfaces with cytosolic signalling proteins, e.g. G-proteins Slide 14 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 General Architecture of a G Protein-coupled Receptor (GPCR) Slide 15 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 Slide 16 of 59 General Architecture of a GPCR MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 GPCR Signalling via G-Proteins & Arrestins Effector enzyme Slide 17 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 GPCR Signalling via Heterotrimeric G Proteins The key feature of GPCRs is their interaction with heterotrimeric GTP-binding proteins (or G-proteins) Heterotrimeric G-proteins play a pivotal role in the signaltransduction pathways initiated by G-protein-coupled receptor (GPCR) activation They are localised at the inner leaflet of the plasma membrane – convey signals from cell-surface GPCR to downstream intracellular effector proteins They act as molecular binary switches – translate agonistGPCR binding into modulation of activity of downstream intracellular effector proteins  biological response Slide 18 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK Heterotrimeric G-Proteins 26 Heterotrimeric G-proteins are composed of 3 different protein subunits: ,  and  Functionally, they consist of two units: an α subunit (Gα) and a tightly associated  complex Both the G and G subunits have lipid extensions that bind & tether the G-protein complex to the plasma membrane The Gα subunit harbours a guanine nucleotide-binding site, which is occupied by GDP in the inactive resting (off) state So far, 21 G, 5 G and 12 G subunits/isoforms have been identified in the human genome  multiple permutations of distinct heterotrimeric complexes Slide 19 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 Heterotrimeric G-protein in the Resting GDP-bound State Gα subunit is composed of 2 domains: a Ras-like domain & an α-helical domain A nucleotide-binding pocket is located between the two domains The Ras-like domain has GTPase activity (hydrolyzes GTP to GPD) & also provides binding sites for the Gβ subunits The N-terminus of Gα is myristoylated or palmitoylated, which results in the attachment of the G protein to the plasma membrane Slide 20 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 Signalling via Heterotrimeric G-Proteins Interaction with agonist-bound GPCR  conformational change  exchange of GDP for GTP on the Gα subunit  dissociation of G-GTP subunit from the G dimer Both G-GTP & the freed G proceed to interact with, and regulate the activity of, unique downstream effector proteins  biological response Ultimately, the activated G-protein returns to the inactive resting (off) state GTPase activity in the Gα subunit hydrolyses bound GTP to GDP Hydrolysis of GTP to GDP is accelerated by regulators of G-protein signalling (RGS) proteins or GTPase-accelerating proteins (GAPs) G-GDP then re-assembles with the G dimer to form the inactive G-protein Slide 21 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 Mechanism of G-Protein Activation By GPCRs Slide 22 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 Slide 23 of 59 The Guanine Nucleotide Cycle of Heterotrimeric G-Proteins MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 Slide 24 of 59 The Guanine Nucleotide Cycle of Heterotrimeric G-Proteins MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 Diversity of GPCR Signalling Mechanisms Signalling via Gα Proteins G-proteins are classified based on their Gα subunits Gα proteins are grouped into 4 families based on their peptide sequence & functional similarities – Gαs, Gαi, Gαq/11, and Gα12/13 protein families Each Gα family can relay GPCR signals to multiple downstream effectors  triggering of different signalling pathways Gαs family – stimulate adenylate cyclase   cAMP Gαi family – inhibit adenylate cyclase   cAMP Gαq/11 family – stimulate phospholipase C-β   IP3 & DAG Gα12/13 family – activate the Rho family of GTPases Slide 25 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK G-Protein Families & Effectors 26 Gα family Gα family members Tissue expression Gαs Gαs, Gαolf Gαi Gαi1, Gαi2, Gαi3, most cell types; high in Gαo, Gαt, Gαg, neurons (Gαo); rod & cone Gαz cells of the eye (Gαt); taste receptor cells (Gαg); neuronal tissues & platelets (Gαz) Gαq, Gα11, most cell types (Gαs); Gα14, Gα16 olfactory neurons (Gαq, Gα11); kidney, lung & liver (Gα14); haematopoietic cells (Gα16) Gα12, Gα13 most cell types Gαq Gα12/13 Slide 26 of 59 MPharm most cell types (Gαs); olfactory neurons (Gαolf) PHA112 Effector proteins & Effect Activate adenylate cyclase Inhibit adenylate cyclase Activate cGMP phosphodiesterase Activate phospholipase C-β Modulate Rho & RasGEFs Receptor Superfamilies - GPCRs WEEK 26 GPCR-mediated Signalling Pathways Slide 27 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 GPCR-mediated Signalling Pathways Slide 28 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 GPCR-mediated Signalling Pathways Slide 29 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 G-mediated Signalling Pathways Most G proteins mediate GPCR signalling by regulating the levels of intracellular regulatory molecules, called second messengers The second messengers regulate the activity of multiple downstream effector proteins  biological response Key second messengers include: cAMP, IP3 and Ca2+ The cAMP signalling pathway Gs-GTP activates Adenylyl Cyclase (AC)   cAMP Gi/o-GTP inhibits Adenylyl Cyclase (AC)   cAMP The Inositol 1,4,5-trisphosphate/calcium signalling pathway Gq/11-GTP activates Phospholipase C-β (PLCβ)   IP3 & DAG   Ca2+ Slide 30 of 59 MPharm PHA112 Receptor Superfamilies - GPCRs WEEK 26 G-mediated Signalling Pathways IP3 cAMP PATHWAY Slide 31 of 59 MPharm PHA112 IP3/Ca2+ PATHWAY Receptor Superfamilies - GPCRs

Use Quizgecko on...
Browser
Browser